Ogrinc Katarina, Kastrin Andrej, Lotrič-Furlan Stanka, Bogovič Petra, Rojko Tereza, Cerar-Kišek Tjaša, Ružić-Sabljić Eva, Wormser Gary P, Strle Franc
Department of Infectious Diseases, University Medical Center Ljubljana, 1000 Ljubljana, Slovenia.
Institute for Biostatistics and Medical Informatics, Faculty of Medicine, University of Ljubljana, 1000 Ljubljana, Slovenia.
J Clin Med. 2020 Sep 16;9(9):2995. doi: 10.3390/jcm9092995.
Statins have anti-inflammatory and potentially antimicrobial activity, but whether they have a beneficial effect on the course of infectious diseases is controversial. In this study, we assessed the impact of pre-existing statin use on the course and outcome of Lyme neuroborreliosis manifested as meningoradiculitis (Bannwarth's syndrome). One hundred and twenty three consecutive patients with Bannwarth's syndrome, of whom 18 (14.6%) were being treated with statins, were included in the study. To assess the influence of statin use on the course and outcome of the disease, univariate and multivariable analyses were performed. No statistically significant association was found between statin pre-treatment and the clinical manifestations, laboratory test results, and outcome of Bannwarth's syndrome. In conclusion, pre-existing use of statins did not significantly impact either the clinical presentation or the outcome of Bannwarth's syndrome.
他汀类药物具有抗炎和潜在的抗菌活性,但它们对传染病病程是否有有益影响存在争议。在本研究中,我们评估了预先使用他汀类药物对表现为脑膜神经根炎(班诺瓦特综合征)的莱姆病神经型疏螺旋体病病程和结局的影响。连续123例班诺瓦特综合征患者纳入研究,其中18例(14.6%)正在接受他汀类药物治疗。为评估他汀类药物使用对疾病病程和结局的影响,进行了单变量和多变量分析。未发现他汀类药物预处理与班诺瓦特综合征的临床表现、实验室检查结果及结局之间存在统计学显著关联。总之,预先使用他汀类药物对班诺瓦特综合征的临床表现或结局均无显著影响。